Altered age‐linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT‐preAD study) with high brain amyloid load

INTRODUCTION: An effective therapy has not yet been developed for Alzheimer's disease (AD), in part because pathological changes occur years before clinical symptoms manifest. We recently showed that decreased plasma DYRK1A identifies individuals with mild cognitive impairment (MCI) or AD, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Delabar, Jean M., Ortner, Marion, Simon, Stephanie, Wijkhuisen, Anne, Feraudet‐Tarisse, Cecile, Pegon, Jonathan, Vidal, Emma, Hirschberg, Yael, Dubois, Bruno, Potier, Marie‐Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331462/
https://www.ncbi.nlm.nih.gov/pubmed/32642550
http://dx.doi.org/10.1002/trc2.12046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331462/
https://www.ncbi.nlm.nih.gov/pubmed/32642550
http://dx.doi.org/10.1002/trc2.12046

Ejemplares similares